RJA
QDEL icon

Ross\Johnson & Associates’s QuidelOrtho QDEL Stock Holding History

Ross\Johnson & Associates’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Hold
1
– – ﹤0.01% 364
2026
Q1 		$16 Sell
1
-2
-67% -$49 ﹤0.01% 214
2025
Q4 		$86 Buy
3
+2
+200% +$54 ﹤0.01% 318
2025
Q3 		$29 Hold
1
– – ﹤0.01% 212
2025
Q2 		$29 Hold
1
– – ﹤0.01% 210
2025
Q1 		$35 Buy
+1
New +$41 ﹤0.01% 353

Other funds holding QDEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ross\Johnson & Associates's QDEL Position: Q2 2026 in Review

Ross\Johnson & Associates held its QuidelOrtho (QDEL) position steady in Q2 2026 at 1 share worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Ross\Johnson & Associates first reported a position in QDEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $86 in Q4 2025. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Ross\Johnson & Associates held 1 share of QuidelOrtho worth $18 as of Q2 2026.
  • Ross\Johnson & Associates left its QuidelOrtho share count unchanged in Q2 2026.
  • QuidelOrtho made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #364 holding.
  • Ross\Johnson & Associates first reported a position in QuidelOrtho in Q1 2025 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's QuidelOrtho position peaked at $86 in Q4 2025.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.